gag gene. In addition, the nucleotide sequence of the c-myc gene from tumor LL3 differs from the published sequence of the normal c-myc coding region at 3 positions of 180 determined. One of these changes, a silent nucleotide transition, is documented as a somatic mutation by restriction endonuclease mapping. It is flanked by two other candidate tumor-specific point mutations, one of which predicts an amino acid replacement, Pro --Thr at position 63. Thus, additional lesions that may affect the expression of viral genes and the quantity and nature of the putative c-myc gene product occur in provirally mutated c-myc alleles and may contribute to tumor progression.
Avian leukosis viruses (ALVs) are a family of weakly oncogenic, replication-competent retroviruses with a generalized proviral structure 5'.. .LTR-gag-pol-env-LTR...3', in which LTR denotes long terminal repeat. The viruses do not contain transforming genes, but they induce tumors, predominantly bursal lymphomas, after a long latency period. Histopathological and epidemiological analysis indicates that lymphoma formation is a multi-stage phenomenon (1, 2) .
Recent experiments support the notion that ALVs contribute to this process by acting as insertional mutagens (3) (4) (5) (6) (7) (8) .
The majority of ALV-induced lymphomas exhibit proviral integrations adjacent to the c-myc gene, the cellular homologue of the putative transforming gene (v-myc) of the acute leukemia virus MC29 (5) (6) (7) (8) . The tumors contain elevated levels of c-myc-specific transcripts, irrespective of the relative configurations of the c-myc and proviral transcriptional units (5, 6) . Potent transcriptional promoting and enhancing activities located within the proviral LTRs are implicated in the over-expression of the c-myc gene. Accordingly, the deletions frequently exhibited by proviruses linked to c-myc always spare at least one LTR (3, 4, 7) .
The high frequency of c-myc-linked integrations is not thought to reflect an affinity for c-myc sequences as an insertional substrate; most experimental findings are consistent with random retroviral integrations into the host genome (9) . Integrations within the c-myc locus probably bestow a selective advantage that would account for the clonality of bursal lymphomas. However, the nature as well as the quantity of the putative c-myc gene product may figure in the outgrowth of tumor cells. For example, the avian bursal lymphoma cell lines RP9, B1, H1, and BK25 encode myc-related proteins that differ in size (10) .
To understand the mechanism and repercussions of c-myc activation, we have generated molecular clones of activated c-myc alleles suitable for both structural and functional analysis. These clones were derived from previously described bursal lymphomas (3, 6) induced by a plaque-purified stock of the ALV, Rous-associated virus-2 (RAV-2). Partial sequence analysis of two such alleles reveals that a number of changes in addition to the primary insertion have occurred. These changes may confer selective advantages and contribute to multistep progression towards the malignant phenotype.
METHODS
Molecular Cloning. Tumor LL4 DNA was digested to completion with BamHI and enriched for c-myc sequences by rate zonal sedimentation. Approximately 3 Ag of the fractionated DNA was ligated to 7 pug of BamHI-digested bacteriophage Charon 30 "arms" (11) , prepared by the method of Maniatis et al. (12) . The ligation products were packaged in vitro (13) . Recombinant phage were plated on Escherichia coli KH802 on square 24-cm plates (14) . Plaque hybridization yielded one phage, XLL4, which hybridized with a radiolabeled Pst I restriction fragment extending from nucleotide 158 to nucleotide 1676 of v-myc (15) and also with a cDNA probe specific for the U5 domain of the Rous sarcoma virus LTR (3). The 10-kilobase (kb) BamHI insert fragment of XLL4 was subcloned into a derivative of pBR322 (16) lacking the EcoRI restriction site (a gift from W. DeLorbe) to yield the plasmid pLL4. Three subclones were derived from the recombinant bacteriophage that span the provirally linked c-myc allele in tumor LL3 (6) . Both pLL3Ab and pLL3Eb contain Bgl II fragments inserted into the BamHI site of pBR322. pLL3Ab contains a 9-kb Bgl II fragment that includes 5' c-myc flanking sequences and the 3' half of the ALV provirus. pLL3Eb contains a 7-kb Bgl II fragment that includes the 5' half of the provirus and c-myc sequences homologous to v-myc. A 0.9-kb Pst I fragment was excised from pLL3Eb and inserted into the plasmid pUC8 (17 (3, 6) . The tumor contains abundant levels of mosaic transcripts initiated within the LTR and extending into c-myc (6) . Restriction mapping of genomic DNA from tumor LL4 indicated that the activated c-myc locus was contained within a 10-kb BamHI fragment (unpublished data). This fragment was cloned into the bacteriophage X vector Charon 30 and subcloned to yield the plasmid pLL4. The proviral insertion in pLL4 was documented by a comparison to pc-myc (21), an analogous subclone derived from a wild-type c-myc gene (Fig. 1A) . Digests of pLL4 and pcmyc were electrophoresed in parallel. In each pair of digests (lanes 1/2 and 3/4), a restriction fragment present in pc-myc was replaced by a larger fragment derived from pLL4. The increase in fragment size, 0.35-0.40 kb, is in accord with tumor LL4 containing a solo LTR. This prediction was verified by nucleotide sequence determination. The pLL4 LTR is missing the terminal dinucleotides A-A and T-T of the unintegrated retroviral genome and is bracketed by a 6-base-pair (bp) direct repeat of cellular DNA, features characteristic of a normal proviral integration event (Fig. 1B) . Furthermore, the normal c-myc sequence contains only one copy of the hexanucleotide G-T-T-T-G-C, which flanks the LL4 LTR (M. Linial, C.-K. Shih, and W. Hayward, personal communication). The LTR is inserted into c-myc in the same transcriptional direction, slightly upstream of 12 nucleotides, G-T-G-C-A-C-G-G-C-C-A-G, present in v-myc but absent from the two known c-myc exons (23) . These nucleotides are flanked on their 3' side by a consensus splice donor sequence and could define the 3' boundary of a third c-myc exon -450 bp upstream from the first of the two known exons. In any event, the LL4 insertion appears to lie within the transcribed portion of the c-myc gene.
Sequence Analysis of a c-myc-Linked ALV Provirus from
Tumor LL3. Previous analysis of bursal lymphoma LL3 established that it harbors a defective RAV-2 provirus upstream and in the opposite transcriptional orientation from the two coding c-myc exons (6) . This arrangement has been found in three other tumors and was correlated in at least some instances with an estimated 20-fold increase of c-mycspecific transcripts (3, 6) . Expression of c-myc in these tumors is thought to be potentiated by a transcription-enhancing activity present in the proviral DNA. Sequence analysis of the LL3 provirus defined an internal deletion anticipated from restriction mapping data. The deletion starts between 15 and 17 bp downstream of the 5' LTR boundary and extends approximately 1100 bp to a position within the coding sequence for the gag polypeptide p27 (ref. 24 ; Fig. 2) . The deletion appears to have occurred by means of a crossover within a dinucleotide shared between the transcribed leader and the p27 sequence. The deletion removes three signal sequences from the proviral genome: (i) the ATG initiation codon for the gag and gag-pol polyproteins (24); (ii) the splice donor site used in the biogenesis of env mRNA (24, 25) ; and (iii) a signal for the encapsidation of viral genomes into virions (26, 27) . The deletion also removes one nucleotide from the tRNATrI primer binding site (24, 28) .
Sequences spanning the LL3 provirus/host cell junction and extending into the v-myc homology region confirm the inverted orientation of the provirus with respect to the direction of c-myc transcription ( Fig. 2; unpublished results) . The provirus is inserted into an intron 148 bp 5' of the first large c-myc exon homologous to v-myc. The proviral termini lack the LTR dinucleotides A-A and T-T and are flanked by a 6-base-pair direct repeat of cell DNA, A-T-A-T-A-T.
LTR Sequences. The 5' LTR of LL3 and the solo LTR of LL4 have an identical nucleotide sequence (Fig. 3) ; 20 of 350 positions vary between the sequence of the LL3/LL4 RAV-2 LTR and one previously determined RAV-2 LTR (22). These differences probably reflect the independent origins (29, 30) of the two RAV-2 isolates used by the laboratories involved. The LL3/LL4 RAV-2 sequence is closely related to that of a Rous sarcoma virus LTR clone used Figure 4 shows a Southern transfer analysis (32) of Sac I digests of normal and tumor DNAs isolated from three birds and probed with a myc-specific hybridization reagent. All the samples show a 3.2-kb c-myc fragment whose termini are defined by Sac I sites at position 190 and downstream of the c-myc polyadenylylation site. However, digestion of the LL3 tumor DNA, but not LL3 spleen DNA, also yielded a 24-kb c-myc fragment. We conclude that the loss of the Sac I site in the LL3 c-myc allele cannot be ascribed to allelic polymorphism and is due to a somatic mutation.
Partial sequence analysis of the mutant c-myc allele reveals a silent G -+ A transition in a glutamine codon (number 57), which destroys the Sac I restriction site (Fig. 5) . Two other deviations from the normal c-myc sequence(23) flank the change in codon 57. The first is a silent C -* A replacement in the third position of a proline codon at position 46. 3) (lanes 1, 3, and 5 ) and unaffected spleens (lanes 2, 4, and 6) of the same three birds was digested to completion with Sac I, electrophoresed on 0.6% agarose gel, transferred to a nitrocellulose filter (32) , and hybridized with a radiolabeled 1.5-kb Pst I fragment derived from the v-myc region of MC29 DNA (15) . The faint doublet at 11 and 13 kb corresponds to endogenous viral sequences that are detected by 90 nucleotides of env sequences included in the probe fragment. A 24-kb tumor-specific c-myc Sac I fragment is indicated by one arrow, the other indicates the position of a 3.2-kb fragment derived from the normal c-myc locus.
The second is a conservative C -. A replacement, which converts the proline codon at position 63 to a threonine codon. No known restriction enzyme recognition sites span either codon 46 or 63, precluding a convenient assessment of whether the base changes represent germinal or somatic sequence variation. Indirect evidence that these base variants represent somatic events comes from the comparison of myc DNA sequences from different sources (15, 23, 33, 34) . The three base replacements lie in a domain of the c-myc gene that is highly conserved in v-myc and in chicken, mouse, and human c-myc (Fig. 6) . Thus, an amino acid replacement in this domain may affect the behavior of the c-myc gene product and participate in tumor pathogenesis. DISCUSSION We have analyzed molecular clones of two mutant c-myc genes derived from ALV-induced bursal lymphomas and defined deletion and point mutations, in addition to the insertion mutations, that affect these alleles. Proviral Insertion Sites. Sequence analysis of molecular clones derived from the bursal tumors LL3 and LL4 confirms the position and orientation of the proviral insertions ine c-myc RNA in tumor LL3. Abundant levels of c-myc RNAs were found in a hepatic metastasis of tumor LL7, which has a similarly disposed proviral integration (6) . These RNA-species did not contain virus-specific sequences, suggesting that the LL3/LL7 proviruses may activate a cryptic promoter in the c-myc intron upstream of the first large exon or may enhance transcriptional initiation from the normal cmyc promoter(s). In the latter case, viral sequences would be eliminated by splicing. Proviral Deletions. Proviral deletions are a common feature of ALV-induced lymphomas (3, 4, 7) . The deletions we define here are internal and preclude the expression of viral replicative genes. The breakpoints of the LL3 deletion are in the primer binding site within the leader (L) region and in the gag gene. The deletion removes the gag/gag-pol ATG codon and the splice donor site used to express the env gene. The LL4 deletion removes a whole provirus with the exception of one LTR. Both proviral deletions eliminate sequences necessary for the encapsidation of virion RNA. This packaging signal has been mapped between the splice donor site and the gag gene ATG codon in spleen necrosis virus and Moloney murine leukemia virus (37, 38) , and a similar area of the genome is implicated in the packaging of Rous sarcoma virus (26, 27) . The absence of this signal gives a clue as to the timing of the deletions. The deletions could not have existed in the infecting virus stock and must have occurred within the lymphocytes that underwent clonal expansion to form tumors. The deletions could have arisen during reverse transcription or after establishment of the provirus. The structure of viral DNA in LL4 is more easily reconciled with the latter explanation because the simplest mechanism for the generation of a solo LTR is homologous recombination between the LTRs of an intact provirus. This sequence of events has been documented for murine leukemia proviruses in two experimental contexts (39) (40) (41) and for the retrovirus-like Drosophila transposon gypsy (42) and the Saccharomyces transposon Ty] (43, 44) .
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The high frequency of proviral deletions in lymphomas indicates that selective pressures favor defective genomes because proviruses are not intrinsically unstable. [For example, generation of solo LTRs in other settings occurs at a frequency between 10-6 and 10-7 (39, 41) .] Two types of selection have been proposed (3, 4) . The first is that deletions prevent the expression of viral gene products presented on the cell surface, allowing the tumor to escape immune surveillance. The second is that the proviral deletions facilitate expression of the linked c-myc gene, in turn producing a more malignant lymphocyte. The LL3 and LL4 deletions are clearly compatible with both hypotheses.
Perturbations of proviruses have been correlated with the changes in the expression of linked genes. Thus, the reversion of recessive mutations attributed to murine leukemia virus, gypsy, and TyJ insertions is frequently associated with the generation of solo terminal repeat structures. Reversion to the wild-type (39-42) or cold-sensitive wild-type (43, 44) phenotype is presumably due to an increment in the level of the "target" gene product; however, this has been verified only in one instance (39) . Other experiments concern an RSV-derived provirus linked upstream, and in the same transcriptional orientation, from a preproinsulin gene. Deletion or insertion mutations that decrease transcription initiation from the 5' LTR facilitate the expression of the preproinsulin gene (G. Ju, personal communication). These analogies suggest that the generation of a solo LTR in tumor LL4 might dictate an increase in c-myc gene expression.
Point Mutations in c-myc. Analysis of part of the c-myc oncogene from tumor LL3 has revealed that at least three nucleotides are different from the c-myc gene sequence reported by Watson et al. (23) (Figs. 5 and 6 ). We have proven that one of the changes, a G -* A transition in codon 57, is a 846 Genetics: Westaway et aL Proc. NatL. Acad. Sci. USA 81 (1984) 847 tumor-specific somatic mutation and that the c-myc allele bearing this mutation predominates in DNA extracted from tumor LL3 (Fig. 4) . Features commend the other base variants in codons 47 and 63 as somatic mutations that might contribute to the pathogenesis of the LL3 tumor, specifically their occurrence in a conserved domain of c-myc and the prediction of an amino acid replacement at codon 63 (Fig. 6) . The clustering of the base variants is notable and can be reconciled with two known mutagenic pathways, one of which may operate specifically in lymphoid cells (45) (46) (47) (48) . Furthermore, simultaneous mutation at several clustered positions could account for the coselection of silent mutations and those that alter amino acid sequence.
Are sequence variations in the c-myc gene a common feature of tumors? The codon 57 mutation can be assessed by restriction mapping and is not shared by tumors LL1, LL2 (Fig. 4) , and LL4 ( here define three somatic mutations that have occurred at the c-myc locus in ALV-induced bursal lymphomas. These are proviral integration, proviral deletion, and point mutation within the c-myc coding region. A fourth variation is the amplification of provirally activated c-myc genes in chicken syncytial virus-induced bursal lymphomas (50) . An event at a different genetic locus has been reported by Cooper and co-workers: the activation of a transforming gene B-lym (51) . Although questions about the timing, ubiquity, and pathological correlates of these genetic lesions remain to be answered, their identification supports the contention that tumorigenesis is a multistage phenomenon. We thank Larry Donehower, Betsy Matthews, and Graeme Mardon for gifts of reagents and C.-K. Shih, Terry Rabbitts, Grace Ju, and H.-J. Kung for communication of results prior to publication. We are particularly grateful to Maxine Linial and Bill Hayward for helping us to position our insertions within their unpublished c-myc sequence and for pointing out the location of v-myc sequences absent from known c-myc exons. We also thank J. Marinos for typing the manuscript. This work was supported by grants from the National Institutes of Health and the American Cancer Society.
